Latest News

News

---

Wednesday - September 05, 2018

Second quarter of 2018
Bayer completes biggest acquisition in its history More

---

Friday - August 03, 2018

New Pest Partner app launched for pest controllers, distributors and homeowners
The app is fully customizable by country and for intended users, e.g. professional pest controllers; distributors or home-owners More

---

Tuesday - July 24, 2018

Health Yourself – why you should care about self-care
We’ve seen significant advances in modern medicine, however, consistent with our growing and ageing population and our modern lifestyles, chronic disease is on the rise. Find out what you can do to look after yourself. More

---

Monday - June 11, 2018

Phosphorus just the tonic for needy cows
Strong demand from vets and farmers // Highest amount of phosphorus available for nutritional supplementation More

---

Thursday - May 31, 2018

Treatment to tackle the country’s two leading causes of blindness now funded on the Pharmaceutical Schedule
EYLEA® (aflibercept) is available under PHARMAC funding from 1 June for the treatment of Wet Age Related Macular Degeneration (wet-AMD) and Diabetic Macular Oedema (DMO) More

---

Friday - May 25, 2018

Bayer is making good progress strategically
Acquisition of Monsanto expected to be closed in the near future / 2017 sales and earnings at the prior-year level / Dividend to be raised for the eighth time in succession – to 2.80 euros per share / Start to fiscal 2018 overshadowed by currency effects More

---

Thursday - May 03, 2018

Bayer Q1 2018: Operational business held back by currency effects – Major progress with Monsanto acquisition
Group sales increase by 2.0 percent (Fx & portfolio adj.) to 9.138 billion euros / EBITDA before special items down year on year due to currency effects / Net income declines by 6.2 percent to 1.954 billion euros / Core earnings per share down 1.3 percent at 2.28 euros / European Commission and additional regulators conditionally approve Monsanto acquisition / Currency adjusted Group outlook for 2018 confirmed More

---

Wednesday - April 04, 2018

Combining tradition with modernity:
Bayer hones its brand profile More

---

Wednesday - March 21, 2018

European Commission conditionally approves Bayer’s proposed acquisition of Monsanto
Closing of transaction planned for the second quarter of 2018 More

---

Wednesday - February 28, 2018

Bayer: business at prior-year level – on track with strategy
Group sales increased by 1.5 percent (Fx & portfolio adj.) to 35.015 billion euros / Another record year for Pharmaceuticals / Weak business development at Consumer Health / Crop Science business down against prior year due to situation in Brazil – measures taking effect / EBITDA before special items level year on year at 9.288 billion euros / Net income raised by 61.9 percent to 7.336 billion euros / Core earnings per share increased by 1.0 percent to 6.74 euros / Covestro deconsolidated – additional cash inflows of 4.7 billion euros / Monsanto acquisition expected to close in second quarter of 2018 / Group outlook for 2018: increase in sales (Fx & portfolio adj.), EBITDA before special items and core earnings per share at prior-year level due to currency effects More

---

Previous

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Next